Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Colinz Laboratories Limited

Market Cap 112M 1.18M 1.02M 939K 879K 1.65M 1.67M 11.12M 4.32M 54.53M 4.42M 4.33M 189M P/E Ratio 2024
19.5x
P/E Ratio 2025 36.8x
Enterprise Value 63.01M 663K 573K 528K 494K 927K 941K 6.25M 2.43M 30.65M 2.49M 2.43M 106M EV / Sales 2024
0.43x
EV / Sales 2025 2.04x
Free-Float
31.44%
Yield 2024 *
-
Yield 2025 -
05-25 Padam Dugar, Annjana Dugar, Likhitta Dugar and Antariksh Dugar acquired 15.01% stake in Colinz Laboratories Limited. CI
04-29 Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-24 Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
01-17 Hilsun Foods And Drugs Private Limited signed a letter of intent to acquire Factory Building, Factory Machinery, & Factory Land of Colinz Laboratories Limited for INR 40 million. CI
11-27 Colinz Laboratories Limited Appoints Falguni Kumawat as Company Secretary and Compliance Officer, with Effect from 1 December, 2025 CI
11-08 Colinz Laboratories Limited Announces of Demise Dr. Mani L.S., Founder Director, Company Secretary and Compliance Officer on 7 November 2025 CI
11-03 Colinz Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
31/07/25 Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
21/05/25 Colinz Laboratories Limited Appoints Swapnil Jayesh Madiyar as Additional Director, Effective from May 16, 2025 CI
16/05/25 Colinz Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
04/03/25 Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
30/10/24 Colinz Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
01/10/24 Colinz Laboratories Limited Approves Board Appointments CI
1 day+2.88%
1 week-7.07%
Current month+2.26%
1 month+8.60%
3 months+25.79%
6 months+19.26%
Current year+1.96%
1 week 53.11
Extreme 53.11
64.89
1 month 42
Extreme 42
64.97
Current year 39.31
Extreme 39.31
87.91
1 year 36.11
Extreme 36.11
87.91
3 years 33.35
Extreme 33.35
88.7
5 years 14.55
Extreme 14.55
88.7
10 years 4.8
Extreme 4.8
88.7
Manager TitleAgeSince
Chief Executive Officer 73 -
Director of Finance/CFO - 20/05/2019
Compliance Officer - 01/12/2025
Director TitleAgeSince
Director/Board Member 73 26/11/1990
Director/Board Member 33 08/08/2024
Director/Board Member 76 08/08/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.88%-7.07%-5.30%+48.26% 1.4M
+0.75%+1.55%+6.93%+83.72% 44.96B
-0.20%-5.34%+38.85%+88.89% 33.53B
+0.44%-0.66%-8.69%+43.35% 11.67B
-0.11%+1.85%+12.86%+117.57% 11.62B
+0.59%+0.78%+37.07%+126.43% 8.97B
+2.40%+0.42%+17.89%+42.70% 6.89B
-1.12%+0.77%+40.21%-17.13% 6.55B
+1.37%-0.31%+32.92%+241.77% 6.32B
+0.51%-2.46%-39.66%-6.34% 5.12B
Average +0.75%-1.38%+13.31%+76.92% 13.56B
Weighted average by Cap. +0.42%-0.96%+17.59%+84.26%

Financials

2024 2025
Net sales 70.3M 739K 639K 589K 551K 1.03M 1.05M 6.98M 2.71M 34.19M 2.77M 2.71M 118M 65.28M 686K 593K 547K 512K 960K 975K 6.48M 2.52M 31.75M 2.58M 2.52M 110M
Net income 4.87M 51.18K 44.23K 40.76K 38.18K 71.6K 72.66K 483K 188K 2.37M 192K 188K 8.2M 4.97M 52.22K 45.13K 41.59K 38.95K 73.06K 74.14K 493K 191K 2.42M 196K 192K 8.37M
Net Debt -64.3M -676K -584K -538K -504K -946K -960K -6.38M -2.48M -31.28M -2.54M -2.48M -108M -49.09M -516K -446K -411K -385K -722K -733K -4.87M -1.89M -23.88M -1.94M -1.9M -82.73M
Logo Colinz Laboratories Limited
Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations, particularly in the gynecological sector. It is engaged in the manufacturing and marketing various allopathic, ayurvedic, and nutraceuticals pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. The company has specialized products for Gynecology, cardiology, gastroenterology, and others. Its oncology products include imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, and doxorubicin. Its Ayurvedic products include anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, and memory boosters. Its nutraceuticals products include spirulina tabs/caps, spirulina with vitamins & minerals, omega 3 fatty acid caps in softgel, codliver oil with vitamin caps in soft gel, collagen, and glucosamine & chondroitin tabs.
Employees
65
Date Price Change Volume
12/06/26 54.68 +2.88% 3,172
11/06/26 53.15 -4.92% 3,129
10/06/26 55.90 -4.96% 1,941
09/06/26 58.82 -4.98% 2,863
08/06/26 61.90 +0.41% 1,886
  1. Stock Market
  2. Stocks
  3. 531210 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!